Impact of a Multidisciplinary Approach to Polypharmacy Management in Community-Dwelling Older Adults: Insights From a Specialized Outpatient Clinic

Overview

Journal Aging Med (Milton)

Specialty Geriatrics

Date 2025 Feb 19

PMID 39968007

Authors

Victoria Roncal-Belzunce

Marta Gutierrez-Valencia

Bernardo Abel Cedeno-Veloz

Ramon San Miguel

Itxaso Marin-Epelde

Arkaitz Galbete

Javier Preciado Goldaracena

Maria Irache Ezpeleta

Karmele Garaioa-Aramburu

Nicolas Martinez-Velilla

Affiliations

Soon will be listed here.

Abstract

Objectives: The increase in polypharmacy among older adults increases the risk of drug-related problems, making multidisciplinary interventions essential. This study evaluated the impact of a multidisciplinary polypharmacy consultation on medication management and outcomes in older outpatients.

Methods: This prospective observational study at a Spanish teaching hospital involved geriatricians, clinical pharmacists, and nurses. Older adults (≥ 75 years) with polypharmacy underwent medication review at baseline and at 3 and 6 months. Data on medication use, adherence to Screening Tool of Older Person's Prescriptions (STOOP) criteria, and anticholinergic burden were analyzed.

Results: The study included 104 older adults (mean age 86.2 years; 66% female). An average of 3.6 recommendations per participant was made (63.8% acceptance rate). Common drug-related problems were adverse effects (20%), non-adherence (18.1%), and incorrect dose/regimen (14.4%). Interventions led to an average reduction of 1.7 medications per patient, with 1.3 dosage or regimen changes and 1.1 new prescriptions. The mean number of medications decreased from 9.6 at baseline to 8.9 at 3 months ( < 0.001) and remained below baseline at 6 months. STOPP criteria violations per patient dropped from 1.2 to 1.0 ( = 0.036). Of the 126 medications flagged by STOPP criteria, 68.3% were addressed, 24.6% discontinued, mainly psychotropics, and 89.3% of these discontinuations were maintained. The anticholinergic burden decreased from 1.3 to 1.1 at 3 months ( = 0.036) and remained below baseline at 6 months.

Conclusions: A multidisciplinary clinic effectively managed polypharmacy in older adults by reducing medication load and improving appropriateness per STOPP criteria, highlighting the importance of proactive medication management.

Trial Registration: ClinicalTrials.gov: NCT05408598 (March 1, 2022).

References

Roncal-Belzunce V, Gutierrez-Valencia M, Leache L, Saiz L, Bell J, Erviti J . Systematic review and meta-analysis on the effectiveness of multidisciplinary interventions to address polypharmacy in community-dwelling older adults. Ageing Res Rev. 2024; 98():102317. DOI: 10.1016/j.arr.2024.102317. View

OMahony D, Cherubini A, Renom Guiteras A, Denkinger M, Beuscart J, Onder G . STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023; 14(4):625-632. PMC: 10447584. DOI: 10.1007/s41999-023-00777-y. View

Seto H, Ishimaru N, Ohnishi J, Kanzawa Y, Nakajima T, Shimokawa T . Multidisciplinary Team Deprescribing Intervention for Polypharmacy in Elderly Orthopedic Inpatients: A Propensity Score-matched Analysis of a Retrospective Cohort Study. Intern Med. 2022; 61(16):2417-2426. PMC: 9449626. DOI: 10.2169/internalmedicine.8929-21. View

Liu J, Yu Y, Yan S, Zeng Y, Su S, He T . Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study. BMC Geriatr. 2023; 23(1):75. PMC: 9900971. DOI: 10.1186/s12877-023-03768-7. View

Braithwaite E, Todd O, Atkin A, Hulatt R, Tadrous R, Alldred D . Interventions for reducing anticholinergic medication burden in older adults-a systematic review and meta-analysis. Age Ageing. 2023; 52(9). PMC: 10517713. DOI: 10.1093/ageing/afad176. View

Ang F, Pau J, Koh E, Loh N, Yeoh W, Liang J . Drug-related problems associated with community-dwelling older persons living alone in Singapore. Int J Clin Pharm. 2019; 41(3):719-727. DOI: 10.1007/s11096-019-00813-7. View

Eldesoky E . Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther. 2007; 14(5):488-98. DOI: 10.1097/01.mjt.0000183719.84390.4d. View

Shawaqfeh B, Hughes C, McGuinness B, Barry H . A systematic review of interventions to reduce anticholinergic burden in older people with dementia in primary care. Int J Geriatr Psychiatry. 2022; 37(6). PMC: 9320938. DOI: 10.1002/gps.5722. View

Reumerman M, Richir M, Domela Nieuwenhuis P, Sultan R, Daelmans H, Springer H . The clinical and educational outcomes of an inter-professional student-led medication review team, a pilot study. Eur J Clin Pharmacol. 2020; 77(1):117-123. PMC: 7782385. DOI: 10.1007/s00228-020-02972-3. View

10.

Wang Z, Liu T, Su Q, Luo H, Lou L, Zhao L . Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta-Analysis. Pharmacoepidemiol Drug Saf. 2024; 33(8):e5880. DOI: 10.1002/pds.5880. View

11.

Guthrie B, Kavanagh K, Robertson C, Barnett K, Treweek S, Petrie D . Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ. 2016; 354:i4079. PMC: 4990081. DOI: 10.1136/bmj.i4079. View

12.

Radcliffe E, Servin R, Cox N, Lim S, Tan Q, Howard C . What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis. BMC Geriatr. 2023; 23(1):591. PMC: 10519081. DOI: 10.1186/s12877-023-04256-8. View

13.

Thomas R, Thomas B . A Systematic Review of Studies of the STOPP/START 2015 and American Geriatric Society Beers 2015 Criteria in Patients ≥ 65 Years. Curr Aging Sci. 2019; 12(2):121-154. DOI: 10.2174/1874609812666190516093742. View

14.

Yates L, Valente M, Wadsworth C . Evaluation of Pharmacist Medication Review Service in an Outpatient Heart Failure Clinic. J Pharm Pract. 2019; 33(6):820-826. DOI: 10.1177/0897190019842696. View

15.

Hilmer S, Mager D, Simonsick E, Cao Y, Ling S, Windham B . A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007; 167(8):781-7. DOI: 10.1001/archinte.167.8.781. View

16.

Aharaz A, Rasmussen J, McNulty H, Cyron A, Fabricius P, Bengaard A . A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial. Metabolites. 2021; 11(4). PMC: 8066016. DOI: 10.3390/metabo11040204. View

17.

Conner K, Wyman P, Goldston D, Bossarte R, Lu N, Kaukeinen K . Two Studies of Connectedness to Parents and Suicidal Thoughts and Behavior in Children and Adolescents. J Clin Child Adolesc Psychol. 2014; 45(2):129-40. DOI: 10.1080/15374416.2014.952009. View

18.

Parker S, McCue P, Phelps K, McCleod A, Arora S, Nockels K . What is Comprehensive Geriatric Assessment (CGA)? An umbrella review. Age Ageing. 2017; 47(1):149-155. DOI: 10.1093/ageing/afx166. View

19.

Duncan P, Duerden M, Payne R . Deprescribing: a primary care perspective. Eur J Hosp Pharm. 2019; 24(1):37-42. PMC: 6451545. DOI: 10.1136/ejhpharm-2016-000967. View

20.

Corsonello A, Pedone C, Incalzi R . Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2009; 17(6):571-84. DOI: 10.2174/092986710790416326. View